AI and human expertise, structured for real world execution
Channel Health develops AI driven innovation platforms for regulated industries, combining system intelligence with domain expertise. Our platforms, GenovAI and IngredAgent, are designed to support end to end product development, from early concept to validated formulation decisions.
AI-enabled formulation and excipient intelligence for structured ingredient decisions.
A hybrid innovation team for R&D, regulatory and commercial decisions
We operate as a hybrid team combining AI systems with real world expertise across R&D, regulatory, medical and commercial functions.
Not a tool.
Not a chatbot.
A dedicated AI human system designed to work alongside your organisation.
A hybrid innovation team for R&D, regulatory and commercial decisions
We operate as a hybrid team combining AI systems with real world expertise across R&D, regulatory, medical and commercial functions.
Not a tool.
Not a chatbot.
A dedicated AI human system designed to work alongside your organisation.
AI platforms for formulation and innovation
Developed by Channel Health
GenovAI®
sup>
Virtual innovation teams running end to end product development sprints. Simulating cross functional decision making to accelerate concept to launch readiness.